Annual Operating Expenses
$189.19 M
+$88.44 M+87.77%
December 31, 2023
Summary
- As of February 26, 2025, NAMS annual total operating expenses is $189.19 million, with the most recent change of +$88.44 million (+87.77%) on December 31, 2023.
- During the last 3 years, NAMS annual operating expenses has risen by +$182.70 million (+2814.41%).
- NAMS annual operating expenses is now at all-time high.
Performance
NAMS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$52.98 M
-$698.00 K-1.30%
September 30, 2024
Summary
- As of February 26, 2025, NAMS quarterly total operating expenses is $52.98 million, with the most recent change of -$698.00 thousand (-1.30%) on September 30, 2024.
- Over the past year, NAMS quarterly operating expenses has stayed the same.
- NAMS quarterly operating expenses is now -5.38% below its all-time high of $55.99 million, reached on March 31, 2024.
Performance
NAMS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NAMS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +87.8% | 0.0% |
| 3 y3 years | +2814.4% | - |
| 5 y5 years | +2814.4% | - |
NAMS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +446.0% | -5.4% | +30.1% |
| 5 y | 5-year | at high | +2814.4% | -5.4% | +30.1% |
| alltime | all time | at high | +2814.4% | -5.4% | +30.1% |
NewAmsterdam Pharma Company NV Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $52.98 M(-1.3%) |
| Jun 2024 | - | $53.68 M(-4.1%) |
| Mar 2024 | - | $55.99 M(+12.0%) |
| Dec 2023 | $189.19 M | $50.00 M(-2.4%) |
| Sep 2023 | - | $51.22 M(+25.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $40.72 M(-13.8%) |
| Mar 2023 | - | $47.26 M |
| Dec 2022 | $100.76 M(+190.8%) | - |
| Dec 2021 | $34.65 M(+433.8%) | - |
| Dec 2020 | $6.49 M | - |
FAQ
- What is NewAmsterdam Pharma Company NV annual total operating expenses?
- What is the all time high annual operating expenses for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV annual operating expenses year-on-year change?
- What is NewAmsterdam Pharma Company NV quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NewAmsterdam Pharma Company NV?
- What is NewAmsterdam Pharma Company NV quarterly operating expenses year-on-year change?
What is NewAmsterdam Pharma Company NV annual total operating expenses?
The current annual operating expenses of NAMS is $189.19 M
What is the all time high annual operating expenses for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high annual total operating expenses is $189.19 M
What is NewAmsterdam Pharma Company NV annual operating expenses year-on-year change?
Over the past year, NAMS annual total operating expenses has changed by +$88.44 M (+87.77%)
What is NewAmsterdam Pharma Company NV quarterly total operating expenses?
The current quarterly operating expenses of NAMS is $52.98 M
What is the all time high quarterly operating expenses for NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma Company NV all-time high quarterly total operating expenses is $55.99 M
What is NewAmsterdam Pharma Company NV quarterly operating expenses year-on-year change?
Over the past year, NAMS quarterly total operating expenses has changed by $0.00 (0.00%)